Anlotinib Combined With Docetaxel for Advanced Non-squamous Non-Small Cell Lung Cancer
Clinical trial NCT03750916 · UNKNOWN
Trial details
- NCT number
- NCT03750916
- Sponsor
- Qilu Hospital of Shandong University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-30
- Primary completion
- 2020-11-30
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.